37 /100
MEDIUM RISK
Score updated Jun 14, 2026

RANI — Rani Therapeutics Holdings, Inc. Dilution Risk Tracker

Track RANI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RANI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
20
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.95 below $1 exchange minimum
🔔 Track RANI — Get forecast alerts →

💹 Market Data

Market Cap$130.72M
Shares Outstanding21.41M
FloatN/A
Cash$108.14M
Debt$3.94M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 1.3% shares (2026Q1 vs prior)
75 institutional holders · 49.36M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 9.25M shares
#2 RA CAPITAL MANAGEMENT, L.P. 8.50M shares
#3 SAMSARA BIOCAPITAL, LLC 8.50M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.96M
Days to Cover8.4
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track RANI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RANI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for RANI
📊 RANI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RANI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.